SELLAS Life Sciences - Clinical Biopharmaceutical Company
SELLAS is late-stage clinical biopharmaceutical company, focused on development of novel therapies for a broad range of cancer indications.
SELLAS Life Sciences Group (SLS) Company Profile & Description
2 days ago · SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United …
Sellas Life Sciences Group Inc, SLS:NAQ profile - FT.com
3 days ago · Sellas Life Sciences Group Inc (SLS:NAQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
Assessing SELLAS Life Sciences Group (SLS) Valuation After ...
Dec 25, 2025 · SELLAS Life Sciences Group (SLS) is back on traders’ radar after fresh data from its leukemia program, including strong response rates and supportive FDA designations, …
SELLAS Life Sciences Group stock soars as it nears final ...
Shares of SELLAS Life Sciences Group, Inc. (SLS) traded 17% higher on Monday after the company said that it is approaching the final analysis of its late-stage trial in Acute Myeloid …
SELLAS Life Sciences Provides Update on Pivotal Phase 3
6 days ago · About SELLAS Life Sciences Group, Inc. SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad …
SELLAS Life Sciences Stock Is Surging Higher: What's Going On?
6 days ago · SELLAS Life Sciences Group climbs higher after a premarket drop, reversing course as investors seem to react to new trial‑related updates.